Swedish Spatial Transcriptomics Startup Cubase Bio Secures €1 Million Eurostars Grant for Cardiac Drug Discovery Platform
Swedish spatial‑biology startup Cubase Bio teamed up with Austrian organoid company HeartBeat.bio, receiving about €1 million in Eurostars funding to create the FACTS‑3D project, which combines Cubase Bio’s 3D spatial transcriptomics with HeartBeat.bio’s cardiac organoids for high‑throughput drug discovery targeting myocardial fibrosis.